Avastin shrinks rare ear-nerve tumours in small study
This article was originally published in Scrip
Executive Summary
Roche's Avastin (bevacizumab) shrinks rare ear-nerve tumours caused by the genetic disease neurofibromatosis type 2, a 10-patient study has shown.